Gammaherpesviruses are highly prevalent pathogens that establish life-long infection and are associated with diverse malignancies, including lymphoproliferative diseases and B cell lymphomas. Unlike other viruses that either do not infect B cells or infect B cells transiently, gammaherpesviruses manipulate physiological B cell differentiation to establish life-long infection in memory B cells. Disruption of such viral manipulation by genetic or environmental causes is likely to seed viral lymphomagenesis. In this review, we discuss physiological and unique host and viral mechanisms usurped by gammaherpesviruses to fine tune host B cell biology for optimal infection establishment and maintenance.
Get full access to this article
View all access options for this article.
References
1.
AllenCD, OkadaT, TangHL, and CysterJG. Imaging of germinal center selection events during affinity maturation. Science, 2007; 315:528–531.
2.
AndersPM, MontgomeryND, MontgomerySA, BhattAP, DittmerDP, and DamaniaB. Human herpesvirus-encoded kinase induces B cell lymphomas in vivo. J Clin Invest, 2018; 128:2519–2534.
3.
AricoE, RobertsonKA, BelardelliF, FerrantiniM, and NashAA. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection. Vaccine, 2004; 22:1433–1440.
4.
BabcockGJ, HochbergD, and Thorley-LawsonDA. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity, 2000; 13:497–506.
5.
BassoK, KleinU, NiuH, et al.Tracking CD40 signaling during germinal center development. Blood, 2004; 104:4088–4096.
6.
BejaranoMT, MasucciMG, MorganA, MoreinB, KleinG, and KleinE. Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation. J Virol, 1990; 64:1398–1401.
7.
BekermanE, JeonD, ArdolinoM, and CoscoyL. A role for host activation-induced cytidine deaminase in innate immune defense against KSHV. PLoS Pathog, 2013; 9:e1003748.
8.
BerkovaZ, WangS, SehgalL, PatelKP, PrakashO, and SamaniegoF. Lymphoid hyperplasia and lymphoma in KSHV K1 transgenic mice. Histol Histopathol, 2015; 30:559–568.
9.
BhendePM, DickersonSJ, SunX, FengWH, and KenneySC. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J Virol, 2007; 81:7363–7370.
10.
BlaskovicD, StancekovaM, SvobodovaJ, and MistrikovaJ. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol, 1980; 24:468.
11.
BowdenRJ, SimasJP, DavisAJ, and EfstathiouS. Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol, 1997; 78:1675–1687.
12.
CaldwellRG, WilsonJB, AndersonSJ, and LongneckerR. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity, 1998; 9:405–411.
13.
CattorettiG, PasqualucciL, BallonG, et al.Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell, 2005; 7:445–455.
14.
CesarmanE.Gammaherpesviruses and lymphoproliferative disorders. Annu Rev Pathol, 2014; 9:349–372.
15.
ChungHJ, ChiHS, JangS, and ParkCJ. Epstein-Barr virus infection associated with bone marrow fibrin-ring granuloma. Am J Clin Pathol, 2010; 133:300–304.
16.
CobaledaC, SchebestaA, DeloguA, and BusslingerM. Pax5: the guardian of B cell identity and function. Nat Immunol, 2007; 8:463.
17.
ColemanCB, McGrawJE, FeldmanER, et al.A gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivo. PLoS Pathog, 2014; 10:e1003916.
18.
ColemanCB, NealyMS, and TibbettsSA. Immature and transitional B cells are latency reservoirs for a gammaherpesvirus. J Virol, 2010; 84:13045–13052.
19.
CollinsCM, BossJM, and SpeckSH. Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J Virol, 2009; 83:6484–6493.
20.
CollinsCM, and SpeckSH. Expansion of murine gammaherpesvirus latently infected B cells requires T follicular help. PLoS Pathog, 2014; 10:e1004106.
21.
CollinsCM, and SpeckSH. Interleukin 21 signaling in B cells is required for efficient establishment of murine gammaherpesvirus latency. PLoS Pathog, 2015; 11:e1004831.
22.
CollinsCM, and SpeckSH. Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo. PLoS One, 2012; 7:e33230.
23.
Dalton-GriffinL, WilsonSJ, and KellamP. X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions. J Virol, 2009; 83:7202–7209.
24.
DarrahEJ, JondleCN, JohnsonKE, et al.Conserved gammaherpesvirus protein kinase selectively promotes irrelevant B cell responses. J Virol, 2019; 93:pii: e01760-18.
25.
DecalfJ, Godinho-SilvaC, FontinhaD, MarquesS, and SimasJP. Establishment of murine gammaherpesvirus latency in B cells is not a stochastic event. PLoS Pathog, 2014; 10:e1004269.
26.
DelibriasCC, FloettmannJE, RoweM, and FearonDT. Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes. J Exp Med, 1997; 186:1575–1583.
27.
DentAL, ShafferAL, YuX, AllmanD, and StaudtLM. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science, 1997; 276:589–592.
28.
DickersonSK, MarketE, BesmerE, and PapavasiliouFN. AID mediates hypermutation by deaminating single stranded DNA. J Exp Med, 2003; 197:1291–1296.
29.
DingC, ChenX, DascaniP, et al.STAT3 signaling in B cells is critical for germinal center maintenance and contributes to the pathogenesis of murine models of lupus. J Immunol, 2016; 196:4477–4486.
30.
DraborgA, IzarzugazaJM, and HouenG. How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?. Curr Opin Rheumatol, 2016; 28:398–404.
31.
DunmireSK, GrimmJM, SchmelingDO, BalfourHHJr, and HogquistKA. The incubation period of primary Epstein-Barr virus infection: viral dynamics and immunologic events. PLoS Pathog, 2015; 11:e1005286.
32.
DunmireSK, HogquistKA, and BalfourHH. Infectious mononucleosis. Curr Top Microbiol Immunol, 2015; 390:211–240.
33.
EfstathiouS, HoYM, HallS, StylesCJ, ScottSD, and GompelsUA. Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. J Gen Virol, 1990; 71:1365–1372.
34.
FakhariFD, JeongJH, KananY, and DittmerDP. The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J Clin Invest, 2006; 116:735–742.
35.
FlanoE, KimIJ, MooreJ, WoodlandDL, and BlackmanMA. Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol, 2003; 70:3828–3834.
36.
FleisherGR, CollinsM, and FagerS. Limitations of available tests for diagnosis of infectious mononucleosis. J Clin Microbiol, 1983; 17:619–624.
37.
FowlerP, MarquesS, SimasJP, and EfstathiouS. ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol, 2003; 84:3405–3416.
38.
GangappaS, KapadiaSB, SpeckSH, and VirginHW. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol, 2002; 76:11460–11468.
39.
GarganoLM, MoserJM, and SpeckSH. Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J Virol, 2008; 82:3853–3863.
40.
GauldSB, De SantisJL, KulinskiJM, et al.Modulation of B-cell tolerance by murine gammaherpesvirus 68 infection: requirement for Orf73 viral gene expression and follicular helper T cells. Immunology, 2013; 139:197–204.
41.
GregorySM, WangL, WestJA, DittmerDP, and DamaniaB. Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines. J Virol, 2012; 86:3916–3923.
42.
GuasparriI, KellerSA, and CesarmanE. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med, 2004; 199:993–1003.
43.
GuasparriI, WuH, and CesarmanE. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep, 2006; 7:114–119.
44.
HerskowitzJ, JacobyMA, and SpeckSH. The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells. J Virol, 2005; 79:2261–2273.
45.
HudnallSD, ChenT, AllisonP, TyringSK, and HeathA. Herpesvirus prevalence and viral load in healthy blood donors by quantitative real-time polymerase chain reaction. Transfusion, 2008; 48:1180–1187.
46.
JohnsonKE, LangePT, JondleCN, et al. B cell-intrinsic SHP1 expression promotes gammaherpesvirus-driven germinal center response and the establishment of chronic infection. J Virol, 2019 [Epub ahead of print]. doi: 10.1128/JVI.01232-19.
47.
KalchschmidtJS, Bashford-RogersR, PaschosK, et al.Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells. J Exp Med, 2016; 213:921–928.
48.
KayeKM, IzumiKM, and KieffE. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A, 1993; 90:9150–9154.
49.
KerfootSM, YaariG, PatelJR, et al.Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity, 2011; 34:947–960.
50.
KhalilAM, CambierJC, and ShlomchikMJ. B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science, 2012; 336:1178–1181.
51.
KhalilAM, CambierJC, and ShlomchikMJ. B cell signal transduction in germinal center B cells is short-circuited by increased phosphatase activity. Science, 2012; 336:1178.
52.
KieserA, and SterzKR. The latent membrane protein 1 (LMP1). Curr Top Microbiol Immunol, 2015; 391:119–149.
53.
KimIJ, FlanoE, WoodlandDL, and BlackmanMA. Antibody-mediated control of persistent g-herpesvirus infection. J Immunol, 2002; 168:3958–3964.
54.
KitanoM, MoriyamaS, AndoY, et al.Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity, 2011; 34:961–972.
55.
KleinE, TeramotoN, GogolákP, NagyN, and BjörkholmM. LMP-1, the Epstein–Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40. Immunol Lett, 1999; 68:147–154.
56.
KleinU, and Dalla-FaveraR. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol, 2008; 8:22.
57.
KleinU, TuY, StolovitzkyGA, et al.Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A, 2003; 100:2639–2644.
58.
KrugLT, MoserJM, DickersonSM, and SpeckSH. Inhibition of NF-κB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog, 2007; 3:97–118.
59.
KuoTC, ShafferAL, HaddadJ, ChoiYS, StaudtLM, and CalameK. Repression of BCL-6 is required for the formation of human memory B cells in vitro. J Exp Med, 2007; 204:819–830.
60.
KurthJ, HansmannML, RajewskyK, and KuppersR. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci U S A, 2003; 100:4730–4735.
61.
LaichalkLL, and Thorley-LawsonDA. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol, 2005; 79:1296–1307.
62.
LarsenM, SauceD, DebackC, et al.Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog, 2011; 7:e1002328.
63.
LiH, IkutaK, SixbeyJW, and TibbettsSA. A replication-defective {gamma}-herpesvirus efficiently establishes long-term latency in macrophages but not B cells in vivo. J Virol, 2008; 82: 8500–8508.
64.
LiangX, CollinsCM, MendelJB, IwakoshiNN, and SpeckSH. Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog, 2002; 5:e1000677.
65.
LinYW, WangKJ, LeiHY, et al.Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol, 2002; 76:12242–12249.
66.
LorenzU.SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev, 2009; 228:342–359.
67.
MaS.-D., YuX, MertzJE, et al.An Epstein-Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol, 2012; 86:7976–7987.
68.
MaSD, HegdeS, YoungKH, et al.A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol, 2011; 85:165–177.
69.
MaSD, TsaiMH, Romero-MastersJC, et al.Latent membrane protein 1 (LMP1) and LMP2A collaborate to promote Epstein-Barr virus-induced B cell lymphomas in a cord blood-humanized mouse model but are not essential. J Virol, 2017; 91:pii: e01928-16.
70.
MaSD, XuX, PlowshayJ, et al.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. J Clin Invest, 2015; 125:304–315.
71.
MancaoC, AltmannM, JungnickelB, and HammerschmidtW. Rescue of “crippled” germinal center B cells from apoptosis by Epstein-Barr virus. Blood, 2005; 106:4339–4344.
72.
MartynCN, CruddasM, and CompstonDA. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry, 1993; 56:167–168.
73.
MatarCG, RangaswamyUS, WakemanBS, IwakoshiN, and SpeckSH. Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1. J Virol, 2014; 88:11600–11610.
74.
MattaH, and ChaudharyPM. Activation of alternative NF-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A, 2004; 101:9399–9404.
75.
MbokoWP, OlteanuH, RayA, et al.Tumor suppressor interferon-regulatory factor 1 counteracts the germinal center reaction driven by a cancer-associated gammaherpesvirus. J Virol, 2016; 90:2818–2829.
76.
MbokoWP, OlteanuH, RayA, et al.Tumor suppressor IRF-1 counteracts germinal center reaction driven by a cancer-associated gammaherpesvirus. J Virol, 2015; 90:2818–2829.
77.
McClellanKB, GangappaS, SpeckSH, and VirginHW. Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog, 2006; 2:e58.
78.
MeijP, LeenA, RickinsonAB, et al.Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2. Int J Cancer, 2002; 99:93–99.
79.
MesriEA, CesarmanE, ArvanitakisL, et al.Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissable virus that infects B cells. J Exp Med, 1996; 183:2385–2390.
80.
MinhasV, and WoodC. Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus. Viruses, 2014; 6:4178–4194.
81.
MiyashitaEM, YangB, LamKM, CrawfordDH, and Thorley-LawsonDA. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell, 1995; 80:593–601.
82.
MoniniP, ColombiniS, SturzlM, et al.Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood, 1999; 93:4044–4058.
83.
MooreKW, VieiraP, FiorentinoDF, TrounstineML, KhanTA, and MosmannTR. Homology of cytokine synthesis inhibitory factor (il-10) to the Epstein-Barr virus gene BCRFI. Science, 1990; 248:1230–1234.
84.
MoormanNJ, WillerDO, and SpeckSH. The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol, 2003; 77:10295–10303.
85.
MorscioJ, DierickxD, and TousseynT. Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?. Clin Dev Immunol, 2013; 2013:150835.
MuramatsuM, KinoshitaK, FagarasanS, YamadaS, ShinkaiY, and HonjoT. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell, 2000; 102:553–563.
88.
NealyMS, ColemanCB, LiH, and TibbettsSA. Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection. J Virol, 2010; 84:7523–7534.
89.
NeraK.-P., KohonenP, NarviE, et al.Loss of Pax5 promotes plasma cell differentiation. Immunity, 2006; 24:283–293.
90.
NicholasJ, RuvoloVR, BurnsWH, et al.Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med, 1997; 3:287–292.
91.
OkCY, LiL, Xu-MonetteZY, et al.Prevalence and clinical implications of Epstein-Barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res, 2014; 20:2338–2349.
92.
PhanRT, and Dalla-FaveraR. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature, 2004; 432:635–639.
93.
PiroozmandA, Haddad KashaniH, and ZamaniB. Correlation between Epstein-Barr virus infection and disease activity of systemic lupus erythematosus: a cross-sectional study. Asian Pac J Cancer Prev, 2017; 18:523–527.
94.
RangaswamyUS, and SpeckSH. Murine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cells. PLoS Pathog, 2014; 10:e1003858.
95.
RappoccioloG, JenkinsFJ, HenslerHR, et al.DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol, 2006; 176:1741–1749.
96.
ReddySS, ForemanHC, SiouxTO, et al.Ablation of STAT3 in the B cell compartment restricts gammaherpesvirus latency in vivo. MBio, 2016; 7:pii: e00723-16.
97.
RekowMM, DarrahEJ, MbokoWP, LangePT, and TarakanovaVL. Gammaherpesvirus targets peritoneal B-1 B cells for long-term latency. Virology, 2016; 492:140–144.
98.
RobbianiDF, DeroubaixS, FeldhahnN, et al.Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma. Cell, 2015; 162:727–737.
99.
Romero-MastersJC, OhashiM, DjavadianR, et al.An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog, 2018; 14:e1007221.
100.
RoughanJE, and Thorley-LawsonDA. The intersection of Epstein-Barr virus with the germinal center. J Virol, 2009; 83:3968–3976.
101.
RoussetF, GarciaE, DefranceT, et al.Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A, 1992; 89:1890–1893.
102.
RoyS, PavitrakarD, GunjikarR, AyachitVM, BondreVP, and SapkalGN. Monocytes and B cells support active replication of Chandipura virus. BMC Infect Dis, 2016; 16:487.
103.
SaitoM, GaoJ, BassoK, et al.A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell, 2007; 12:280–292.
104.
SangsterMY, TophamDJ, D'CostaS, et al.Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol, 2000; 164:1820–1828.
105.
ShimakageM, KimuraM, YanomaS, et al.Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch Virol, 1999; 144:157–166.
106.
SiegelAM, HerskowitzJH, and SpeckSH. The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog, 2008; 4:e1000039.
107.
SinSH, and DittmerDP. Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma. Blood, 2013; 121:2952–2963.
108.
SmattiMK, Al-SadeqDW, AliNH, PintusG, Abou-SalehH, and NasrallahGK. Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update. Front Oncol, 2018; 8:211.
109.
SteinH, BonkA, TolksdorfG, LennertK, RodtH, and GerdesJ. Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem, 1980; 28:746–760.
110.
SteinbruckL, GustemsM, MedeleS, SchulzTF, LutterD, and HammerschmidtW. K1 and K15 of Kaposi's sarcoma-associated herpesvirus are partial functional homologues of latent membrane protein 2A of Epstein-Barr virus. J Virol, 2015; 89:7248–7261.
111.
StevensonPG, and DohertyPC. Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol, 1998; 72:943–949.
112.
StevensonPG, and DohertyPC. Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol, 1999; 73:1075–1079.
113.
StewartJP, UsherwoodEJ, RossA, DysonH, and NashT. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med, 1998; 187:1941–1951.
114.
SunCC, and Thorley-LawsonDA. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol, 2007; 81:13566–13577.
115.
TamirI, Dal PortoJM, and CambierJC. Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction. Curr Opin Immunol, 2000; 12:307–315.
116.
TarakanovaVL, StanitsaE, LeonardoSM, BigleyTM, and GauldSB. Conserved gammaherpesvirus kinase and histone variant H2AX facilitate gammaherpesvirus latency in vivo. Virology, 2010; 405:50–61.
117.
TarakanovaVL, SuarezFS, TibbettsSA, et al.Murine gammaherpesvirus 68 infection induces lymphoproliferative disease and lymphoma in BALB á2 microglobulin deficient mice. J Virol, 2005; 79:14668–14679.
118.
TerrellS, and SpeckSH. Murine gammaherpesvirus M2 antigen modulates splenic B cell activation and terminal differentiation in vivo. PLoS Pathog, 2017; 13:e1006543.
119.
ThackerEL, MirzaeiF, and AscherioA. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol, 2006; 59:499–503.
Thorley-LawsonDA, and GrossA. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med, 2004; 350:1328–1337.
122.
ThornburgN, KulwichitW, EdwardsR, ShairK, BendtK, and Raab-TraubN. LMP1 signaling and activation of NF-κB in LMP1 transgenic mice. Oncogene, 2006; 25:288.
123.
TibbettsSA, McClellanJS, GangappaS, SpeckSH, and VirginHW. Effective vaccination against long-term gammaherpesvirus latency. J Virol, 2003; 77:2522–2529.
124.
TotonchyJ, OsbornJM, ChadburnA, et al.KSHV induces immunoglobulin rearrangements in mature B lymphocytes. PLoS Pathog, 2018; 14:e1006967.
125.
TracySI, KakalachevaK, LunemannJD, LuzuriagaK, MiddeldorpJ, and Thorley-LawsonDA. Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol, 2012; 86:12330–12340.
126.
TrapecarM, KhanS, CohnBL, WuF, and SanjabiS. B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol, 2018; 11:1158–1167.
127.
UchidaJ, YasuiT, Takaoka-ShichijoY, et al.Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science, 1999; 286:300–303.
128.
UppalT, BanerjeeS, SunZ, VermaS, and RobertsonE. KSHV LANA—the master regulator of KSHV latency. Viruses, 2014; 6:4961–4998.
129.
UsherwoodEJ, RossAJ, AllenDJ, and NashAA. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J Gen Virol, 1996; 77:627–630.
130.
UsherwoodEJ, StewartJP, RobertsonK, AllenDJ, and NashAA. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol, 1996; 77:2819–2825.
131.
VirginHW, LatreilleP, WamsleyP, et al.Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol, 1997; 71:5894–5904.
132.
WagnerH, BeinG, BitschA, and KirchnerH. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol, 1992; 30:2826–2829.
133.
WangC, ZhuC, WeiF, et al.Constitutive activation of interleukin-13/STAT6 contributes to Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma cell proliferation and survival. J Virol, 2015; 89:10416–10426.
134.
WangLX, KangG, KumarP, et al.Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection. Proc Natl Acad Sci U S A, 2014; 111:3146–3151.
135.
WeckKE, KimSS, VirginHI, and SpeckSH. B cells regulate murine gammaherpesvirus 68 latency. J Virol, 1999; 73:4651–4661.
136.
WeckKE, KimSS, VirginHW, and SpeckSH. B cells regulate murine gammaherpesvirus 68 latency. J Virol, 1999; 73:4651–4661.
137.
WeckKE, KimSS, VirginHW, and SpeckSH. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol, 1999; 73:3273–3283.
138.
WilmoreJR, MaueAC, and RochfordR. Plasmodium chabaudi infection induces AID expression in transitional and marginal zone B cells. Immun Inflamm Dis, 2016; 4:497–505.
139.
WilsonSJ, TsaoEH, WebbBL, et al.X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J Virol, 2007; 81:13578–13586.
140.
YeB, CattorettiG, ShenQ, et al.The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet, 1997; 16:161–170.
141.
YuF, HaradaJN, BrownHJ, et al.Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog, 2007; 3:e44.
